Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.92 USD
Change Today +0.10 / 3.55%
Volume 59.4K
TRXC On Other Exchanges
Symbol
Exchange
NYSE Amex
As of 8:04 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

transenterix inc (TRXC) Snapshot

Open
$2.83
Previous Close
$2.82
Day High
$2.93
Day Low
$2.79
52 Week High
04/2/14 - $14.00
52 Week Low
12/15/14 - $1.40
Market Cap
185.1M
Average Volume 10 Days
108.1K
EPS TTM
$-0.50
Shares Outstanding
63.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TRANSENTERIX INC (TRXC)

Related News

No related news articles were found.

transenterix inc (TRXC) Related Businessweek News

No Related Businessweek News Found

transenterix inc (TRXC) Details

TransEnterix, Inc., a medical device company, focuses on the development and commercialization of a robotic assisted surgical system in the United States and internationally. The company develops SurgiBot System, a single-incision, patient-side robotic-assisted surgery system. The SurgiBot System comprises of SurgiBot Base, a reusable robotic base that provides the platform of the system; the EndoDrive, a single port, surgical access device for abdominal surgery; and the Positioning Arm, a reusable arm that supports and repositions the SurgiBot Base at the operating table. The company also develops and manufactures flexible and rigid laparoscopic surgical instruments that are used in abdominal surgery, such as scissors, graspers, clip appliers, flexible energy device, and suction and irrigation instruments. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.

98 Employees
Last Reported Date: 02/20/15

transenterix inc (TRXC) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $400.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $282.8K
Compensation as of Fiscal Year 2014.

transenterix inc (TRXC) Key Developments

TransEnterix, Inc. Presents at Barclays Global Healthcare Conference, Mar-12-2015 01:35 PM

TransEnterix, Inc. Presents at Barclays Global Healthcare Conference, Mar-12-2015 01:35 PM. Venue: Loews Miami Beach Hotel, 1601 Collins Avenue, Miami, Florida, United States. Speakers: Todd M. Pope, Chief Executive Officer, President and Director.

Transenterix, Inc. Announces Consolidated Unaudited Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014

TransEnterix, Inc. announced consolidated unaudited earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported sales of $134,000 compared with $219,000 for the same period a year ago. Operating loss was $7,800,000 compared with $7,819,000 for the same period a year ago. Net loss was $8,079,000 or $0.13 per basic and diluted share compared with $8,031,000 or $0.21 per basic and diluted share for the same period a year ago. For the year, the company reported sales of $401,000 compared with $1,431,000 for the same period a year ago. Operating loss was $36,609,000 compared with $28,358,000 for the same period a year ago. Net loss was $37,652,000 or $0.64 per basic and diluted share compared with $28,358,000 or $2.23 per basic and diluted share for the same period a year ago. Net cash and cash equivalents used in operating activities was $33,228,000 compared with $21,236,000 for the same period a year ago. Purchase of property and equipment was $2,174,000 compared with $1,377,000 for the same period a year ago.

TransEnterix, Inc. Presents at Raymond James & Associates 36th Annual Institutional Investors Conference, Mar-02-2015 01:05 PM

TransEnterix, Inc. Presents at Raymond James & Associates 36th Annual Institutional Investors Conference, Mar-02-2015 01:05 PM. Venue: JW Marriott Grande Lakes, 4040 Central Florida Parkway, Orlando, FL 32837, United States. Speakers: Joseph P. Slattery, Chief Financial Officer, Principal Accounting Officer and Executive Vice President, Todd M. Pope, Chief Executive Officer, President and Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TRXC:US $2.92 USD +0.10

TRXC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Intuitive Surgical Inc $497.25 USD 0.00
Johnson & Johnson $100.34 USD +0.20
Stryker Corp $92.56 USD +1.03
View Industry Companies
 

Industry Analysis

TRXC

Industry Average

Valuation TRXC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 460.4x
Price/Book 1.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 350.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TRANSENTERIX INC, please visit www.transenterix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.